These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25983146)

  • 1. Dedicated stents for distal left main stenting.
    Grundeken MJ; Magro M; Gil R; Briguori C; Sardella G; Berland J; Wykrzykowska JJ; Serruys PW
    EuroIntervention; 2015; 11 Suppl V():V129-34. PubMed ID: 25983146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryton dedicated bifurcation stent in treatment of unprotected distal left main bifurcation disease.
    Neupane S; Edla S; Ambulgekar N; Zaitoun A; Torey J; Attallah A
    Cardiovasc Revasc Med; 2018 Dec; 19(8S):60-64. PubMed ID: 29793898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
    Kherada NI; Sartori S; Tomey MI; Mennuni MG; Meelu OA; Roy S; Mohanty BD; Baber U; Pyo R; Kovacic JC; Sweeny J; Moreno P; Krishnan P; Dangas GD; Mehran R; Sharma SK; Kini AS
    Int J Cardiol; 2014 Jun; 174(1):13-7. PubMed ID: 24731975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to define bifurcation lesion complexity and how to successfully perform percutaneous treatment.
    Grundeken MJ; Kraak RP; De Winter RJ; Serruys PW; Wykrzykowska JJ
    Minerva Cardioangiol; 2015 Aug; 63(4):253-74. PubMed ID: 25990536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left main and bifurcation stenting.
    Carrié D
    Minerva Cardioangiol; 2012 Oct; 60(5):491-505. PubMed ID: 23018429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to optimize the percutaneous treatment of bifurcated lesions: dedicated stents vs. provisional stenting.
    Alegria-Barrero E; Foin N; Lindsay AC; Paulo M; Hei Chan P; Syrseloudis D; Viceconte N; Martos R; Beatt K; Di Mario C
    Minerva Cardioangiol; 2013 Oct; 61(5):575-90. PubMed ID: 24096251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culotte versus the novel nano-crush technique for unprotected complex bifurcation left main stenting: difference in procedural time, contrast volume and X-ray exposure and 3-years outcomes.
    Rigatelli G; Zuin M; Vassilev D; Dinh H; Giatti S; Carraro M; Zanon F; Roncon L; Dung HT
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):207-214. PubMed ID: 30446919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes of patients with unprotected left main bifurcation lesions treated with 2-stent techniques.
    Pei HJ; Sui YG; Wu YJ; Yang YJ; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Yuan JQ; Chen J; Liu HB; You SJ; Gao RL
    Chin Med J (Engl); 2013 Jul; 126(13):2409-13. PubMed ID: 23823809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
    Chen SL; Sheiban I; Xu B; Jepson N; Paiboon C; Zhang JJ; Ye F; Sansoto T; Kwan TW; Lee M; Han YL; Lv SZ; Wen SY; Zhang Q; Wang HC; Jiang TM; Wang Y; Chen LL; Tian NL; Cao F; Qiu CG; Zhang YJ; Leon MB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1266-76. PubMed ID: 25326748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
    Džavík V; Kaul U; Guagliumi G; Chevalier B; Smits PC; Stuteville M; Li D; Sudhir K; Grube E
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E163-72. PubMed ID: 23225766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of coronary bifurcation lesions: current knowledge and future perspectives.
    Elwany M; Palma GD; Cortese B
    Future Cardiol; 2018 Mar; 14(2):165-179. PubMed ID: 29372810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedicated bifurcation stents - Mechanistic, hardware, and technical aspects.
    Mishra S
    Indian Heart J; 2016; 68(6):841-850. PubMed ID: 27931557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club.
    Lassen JF; Holm NR; Banning A; Burzotta F; Lefèvre T; Chieffo A; Hildick-Smith D; Louvard Y; Stankovic G
    EuroIntervention; 2016 May; 12(1):38-46. PubMed ID: 27173860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which technique for double stenting in unprotected left main bifurcation coronary lesions?
    Roh JH; Santoso T; Kim YH
    EuroIntervention; 2015; 11 Suppl V():V125-8. PubMed ID: 25983145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.